VX22-147-010
12 evidence topics · 1 source
Objective
Location and study date
Study dates and status in the registry record
| Field | Registry entry |
|---|---|
| Recruitment status | “Completed” |
| Study start (actual) | “2023-07-19” |
| Primary completion (actual) | “2023-09-02” |
| Study completion (actual) | “2023-09-02” |
| First posted | “2023-07-21” |
| Last update posted | “2023-09-13” |
| Other study ID numbers | “VX22-147-010” |
Study design
Phase 1, open-label, randomized crossover design
Design details in the registry record
| Field | Registry entry |
|---|---|
| Study type | “Interventional” |
| Phase | “Phase 1” |
| Primary purpose | “Treatment” |
| Allocation | “Randomized” |
| Interventional model | “Crossover Assignment” |
| Masking | “None (Open Label)” |
Eligibility criteria
Age range and healthy volunteers
| Field | Registry entry |
|---|---|
| Ages eligible | “18 Years to 55 Years” |
| Sexes eligible | “All” |
| Accepts healthy volunteers | “Yes” |
Treatment
Three treatment sequences of test and reference tablets, fed and fasted
Study outcomes
Rationale for using relative bioavailability and food effect on cmax and AUC0-inf as the primary endpoints
Registered primary and secondary outcomes
Statistical analysis description
Number of participants (Planned and analyzed)
Enrollment in the registry record
| Field | Registry entry |
|---|---|
| Enrollment (actual) | “21” |
Description of analysis sets
No evidence found.
Results
Participant disposition
No evidence found.
Baseline characteristics
No evidence found.
Efficacy results
No evidence found.
Health-related quality of life and patient-reported outcomes
Not applicable.
Safety results
No evidence found.
Study limitations
Summary: study limitations
VX22-147-010 enrolled 21 healthy adults aged 18 to 55 years at one United States site and compared a test tablet with a reference tablet, and the test tablet fed with fasted, in a three-period crossover with 5-day washouts. The study was completed on 2023-09-02, but the ClinicalTrials.gov record lists no posted results, and no publication or congress abstract reporting its results was identified. The registry record does not state the dose or the composition of the test meal.